Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx

Randomized trial of GvHD Prophylaxis in Haploidentical PBSC Transplantation: ATG, PTCy, and Low-Dose Combination Therapy ashpublications.org/blood/article-…

Ferric Carboxymaltose Increases Fracture Risk in Patients and Reduces Bone Formation in Mice with Iron Deficiency Anemia ashpublications.org/blood/article/…

Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models ashpublications.org/blood/article-…

Tocilizumab as stabilizing frontline treatment in suspected KSHV inflammatory cytokine syndrome ashpublications.org/bloodadvances/…

Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANS ashpublications.org/bloodadvances/…

Pulmonary Complications Following Hematopoietic Cell Transplantation in Patients with Myelofibrosis: astctjournal.org/article/S2666-…

Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome | New England Journal of Medicine nejm.org/doi/full/10.10…

Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial - The Lancet Haematology thelancet.com/journals/lanha…

Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia | New England Journal of Medicine nejm.org/doi/full/10.10…

DB-OTO Gene Therapy for Inherited Deafness | New England Journal of Medicine nejm.org/doi/full/10.10…

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia | New England Journal of Medicine nejm.org/doi/full/10.10…

Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm | Journal of Clinical Oncology ascopubs.org/doi/pdf/10.120…

Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001) | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Remission of TP53-Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33) | JCO Precision Oncology ascopubs.org/doi/abs/10.120…

US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Hematopoietic stem cell transplantation for purine nucleoside phosphorylase deficiency: an EBMT-IEWP retrospective study ashpublications.org/blood/article/…

Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell Lymphoma ashpublications.org/blood/article-…